Welcome to our dedicated page for Cleveland-Cliffs SEC filings (Ticker: CLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cleveland-Cliffs’ disclosures can read like blast-furnace schematics—dense, technical, and spread across hundreds of pages. If you have ever searched for raw-material cost breakdowns or tried to reconcile pellet output with sales guidance, you know the pain of parsing a 300-page annual report. Our platform tackles that challenge head-on.
Stock Titan’s AI digests every filing the moment it hits EDGAR. Whether you need the latest Cleveland-Cliffs insider trading Form 4 transactions or a Cleveland-Cliffs quarterly earnings report 10-Q filing, we surface the numbers and explain what they mean. Real-time alerts flag Cleveland-Cliffs Form 4 insider transactions real-time, while concise notes turn section-by-section jargon into plain English: Cleveland-Cliffs SEC filings explained simply.
Different forms answer different questions:
- The 10-K gives a mine-to-mill view of operations—use our Cleveland-Cliffs annual report 10-K simplified feature to see revenue per ton and furnace utilization trends.
- 10-Q updates quarterly volumes, pricing, and liquidity—perfect for Cleveland-Cliffs earnings report filing analysis.
- Form 4 shows executive stock moves—track Cleveland-Cliffs executive stock transactions Form 4 before market reactions.
- 8-K filings flag unplanned outages, labor agreements, or acquisitions—see Cleveland-Cliffs 8-K material events explained in minutes.
- Proxy statements outline pay packages—our AI highlights Cleveland-Cliffs proxy statement executive compensation without the legal haze.
From monitoring blast-furnace restarts to comparing auto-grade steel shipments, understanding Cleveland-Cliffs SEC documents with AI means making decisions faster and with confidence—all on one page, updated in real time.
Form 4 filing overview – Agilysys, Inc. (AGYS)
Chief Financial Officer William David Wood III reported a single open-market sale of 321 common shares on 1 Jul 2025 at an average price of $113.39 per share, generating proceeds of roughly $36.4 thousand. The transaction was explicitly disclosed as a “sell-to-cover” to satisfy withholding taxes triggered by the vesting of restricted stock on 30 Jun 2025. Following the sale, the CFO still directly owns 47,288 shares of AGYS, indicating only a 0.7 % reduction in his direct equity position.
No derivative transactions were reported, and the filing lists no changes to option holdings. Because the disposition was limited in size and purpose, it is generally interpreted as routine liquidity management rather than a signal of reduced confidence.
Independent Bank Corp. (INDB) – SEC Form 4 filing dated 07/03/2025
Director Kenneth S. Ansin reported a series of share acquisitions on 07/01/2025 that stem from the completed merger of Enterprise Bancorp, Inc. into Independent Bank Corp. The transactions were all coded “A” (acquisition), indicating that no shares were sold.
- Direct ownership: 4,158 shares were received in exchange for approximately 6,930 Enterprise Bancorp shares, and a separate grant of 938 fully-vested restricted shares was awarded under the 2018 Non-Employee Director Stock Plan. Direct holdings now total 5,096 shares.
- Indirect ownership: Multiple family trusts and a spousal account collectively received 641,657 shares through the same stock-for-stock exchange mechanism. Key holdings include 432,481 shares in a family trust and 106,738 shares in a grandchildren’s trust.
In total, Ansin now beneficially owns roughly 646,753 INDB shares (direct + indirect). No derivative securities were reported, and no dispositions occurred. Exchange ratios were based on the last pre-merger closing prices of $39.64 for Enterprise Bancorp and $62.885 for INDB.
The filing primarily reflects mechanical share issuance resulting from the merger rather than open-market insider buying. Nonetheless, the sizable post-merger stake materially increases insider ownership, potentially aligning the director’s interests more closely with common shareholders.
On July 1, 2025, SeaStar Medical Holding Corporation (ICU) Chief Medical Officer Kevin Chung filed a Form 4 disclosing the vesting and conversion of 5,000 restricted stock units (RSUs) into common shares. The transaction was coded “M,” signifying a conversion of derivative equity awards rather than an open-market purchase, and carried a price of $0 per share.
After the transaction, Dr. Chung now directly owns 48,184 ICU shares. This figure incorporates 25,000 shares that were previously reported as unvested RSUs in Table II and have been moved to Table I. The filing also corrects a prior one-share rounding error, and no derivative RSUs remain reportable from this grant.
The RSUs originated from a November 15, 2024 grant of 15,000 units that vest in three equal annual tranches beginning July 1, 2024; the current filing reflects the first installment. Because the shares were received under a pre-arranged compensation plan at no cost, the event does not inject new capital into the company nor constitute an open-market confidence signal. Nevertheless, it modestly increases insider equity alignment and provides transparency regarding executive compensation.